Overview Dividends

(CRI) Carter’s - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1462291097

Apparel,Infant,Children,Accessories

CRI EPS (Earnings per Share)

EPS Growth (3Y CAGR): -33.69%
EPS Trend (3Y Correlation): -46.1%

CRI Revenue

Revenue Growth (3Y CAGR): -6.52%
Revenue Trend (3Y Correlation): -26.1%

Description: CRI Carter’s August 18, 2025

Carters Inc (NYSE:CRI) is a US-based company operating in the Apparel, Accessories & Luxury Goods sub-industry. The company designs, manufactures, and markets branded childrens apparel, accessories, and related products.

To evaluate CRIs investment potential, we need to examine key performance indicators (KPIs) such as revenue growth, gross margin, and operating expenses as a percentage of sales. A review of these metrics can help identify trends and areas for improvement. For instance, a stable or increasing gross margin indicates the companys ability to maintain pricing power and manage production costs.

Key economic drivers for CRI include consumer spending on childrens apparel, demographic trends such as birth rates and population growth, and competition from online retailers. The companys ability to adapt to changing consumer preferences and navigate the shift to e-commerce will be crucial to its long-term success.

CRIs current valuation multiples, including a P/E ratio of 6.74 and a forward P/E of 25.19, suggest a potentially undervalued stock with room for growth. The companys return on equity (RoE) of 16.38% indicates a relatively strong ability to generate profits from shareholder equity.

To further assess CRIs investment potential, we should analyze its financial statements to identify trends in cash flow generation, debt levels, and dividend sustainability. A thorough examination of these factors will help determine whether the companys current valuation is justified and whether its future prospects are promising.

CRI Stock Overview

Market Cap in USD	1,167m
Sub-Industry	Apparel, Accessories & Luxury Goods
IPO / Inception	2003-10-24

CRI Stock Ratings

Growth Rating	-85.0%
Fundamental	52.3%
Dividend Rating	70.6%
Return 12m vs S&P 500	-44.0%
Analyst Rating	2.33 of 5

CRI Dividends

Dividend Yield 12m	6.62%
Yield on Cost 5y	3.03%
Annual Growth 5y	51.97%
Payout Consistency	94.2%
Payout Ratio	53.0%

CRI Growth Ratios

Growth Correlation 3m	78.2%
Growth Correlation 12m	-88.6%
Growth Correlation 5y	-84.8%
CAGR 5y	-20.91%
CAGR/Max DD 3y (Calmar Ratio)	-0.29
CAGR/Mean DD 3y (Pain Ratio)	-0.74
Sharpe Ratio 12m	-0.23
Alpha	-57.01
Beta	1.079
Volatility	51.96%
Current Volume	500.5k
Average Volume 20d	1149.3k
Stop Loss	29.8 (-6%)
Signal	-0.30

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (88.9m TTM) > 0 and > 6% of Revenue (6% = 170.0m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -7.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 22.31% (prev 20.67%; Δ 1.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 151.2m > Net Income 88.9m (YES >=105%, WARN >=100%)

Net Debt (495.5m) to EBITDA (201.2m) ratio: 2.46 <= 3.0 (WARN <= 3.5)

Current Ratio 2.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (35.4m) change vs 12m ago 0.40% (target <= -2.0% for YES)

Gross Margin 46.79% (prev 48.28%; Δ -1.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 116.9% (prev 119.5%; Δ -2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.72 (EBITDA TTM 201.2m / Interest Expense TTM 31.0m) >= 6 (WARN >= 3)

Altman Z'' 3.79

(A) 0.26 = (Total Current Assets 1.13b - Total Current Liabilities 501.7m) / Total Assets 2.47b

(B) 0.35 = Retained Earnings (Balance) 874.4m / Total Assets 2.47b

(D) 0.53 = Book Value of Equity 846.6m / Total Liabilities 1.60b

Total Rating: 3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.32

1. Piotroski 3.50pt = -1.50

2. FCF Yield 5.53% = 2.77

3. FCF Margin 3.25% = 0.81

4. Debt/Equity 0.79 = 2.20

5. Debt/Ebitda 2.46 = -0.89

6. ROIC - WACC (= 1.85)% = 2.32

7. RoE 10.39% = 0.87

8. Rev. Trend -26.06% = -1.95

9. EPS Trend -46.07% = -2.30

What is the price of CRI shares?

As of November 09, 2025, the stock is trading at USD 31.70 with a total of 500,450 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +9.42%, over three months by +24.51% and over the past year by -36.13%.

Is Carter’s a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Carter’s is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 52.32 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRI is around 28.56 USD . This means that CRI is currently overvalued and has a potential downside of -9.91%.

Is CRI a buy, sell or hold?

Carter’s has received a consensus analysts rating of 2.33. Therefor, it is recommend to sell CRI.

Strong Buy: 0
Buy: 0
Hold: 3
Sell: 2
Strong Sell: 1

What are the forecasts/targets for the CRI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	28.8	-9.1%
Analysts Target Price	28.8	-9.1%
ValueRay Target Price	31.3	-1.2%

CRI Fundamental Data Overview November 07, 2025

Market Cap USD = 1.17b (1.17b USD * 1.0 USD.USD)
P/E Trailing = 13.0122
P/E Forward = 16.4474
P/S = 0.4119
P/B = 1.2629
P/EG = 1.81
Beta = 1.079
Revenue TTM = 2.83b USD
EBIT TTM = 146.3m USD
EBITDA TTM = 201.2m USD
Long Term Debt = 498.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 150.5m USD (from shortTermDebt, last quarter)
Debt = 679.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 495.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.66b USD (1.17b + Debt 679.7m - CCE 184.2m)
Interest Coverage Ratio = 4.72 (Ebit TTM 146.3m / Interest Expense TTM 31.0m)
FCF Yield = 5.53% (FCF TTM 92.0m / Enterprise Value 1.66b)
FCF Margin = 3.25% (FCF TTM 92.0m / Revenue TTM 2.83b)
Net Margin = 3.14% (Net Income TTM 88.9m / Revenue TTM 2.83b)
Gross Margin = 46.79% ((Revenue TTM 2.83b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 45.08% (prev 48.14%)
Tobins Q-Ratio = 0.67 (Enterprise Value 1.66b / Total Assets 2.47b)
Interest Expense / Debt = 1.06% (Interest Expense 7.17m / Debt 679.7m)
Taxrate = 21.85% (3.24m / 14.8m)
NOPAT = 114.4m (EBIT 146.3m * (1 - 21.85%))
Current Ratio = 2.26 (Total Current Assets 1.13b / Total Current Liabilities 501.7m)
Debt / Equity = 0.79 (Debt 679.7m / totalStockholderEquity, last quarter 864.6m)
Debt / EBITDA = 2.46 (Net Debt 495.5m / EBITDA 201.2m)
Debt / FCF = 5.39 (Net Debt 495.5m / FCF TTM 92.0m)
Total Stockholder Equity = 855.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.60% (Net Income 88.9m / Total Assets 2.47b)
RoE = 10.39% (Net Income TTM 88.9m / Total Stockholder Equity 855.1m)
RoCE = 10.81% (EBIT 146.3m / Capital Employed (Equity 855.1m + L.T.Debt 498.1m))
RoIC = 8.47% (NOPAT 114.4m / Invested Capital 1.35b)
WACC = 6.62% (E(1.17b)/V(1.85b) * Re(9.99%) + D(679.7m)/V(1.85b) * Rd(1.06%) * (1-Tc(0.22)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 68.44% ; FCFE base≈166.2m ; Y1≈142.1m ; Y5≈110.2m
Fair Price DCF = 40.44 (DCF Value 1.47b / Shares Outstanding 36.4m; 5y FCF grow -17.63% → 3.0% )
EPS Correlation: -46.07 | EPS CAGR: -33.69% | SUE: 0.11 | # QB: 0
Revenue Correlation: -26.06 | Revenue CAGR: -6.52% | SUE: -1.26 | # QB: 0

Additional Sources for CRI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle